HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pagano, D. Articles by Bonser, R. S. Search for Related Content PubMed PubMed Citation Articles by Pagano, D. Articles by Bonser, R. S.

European Journal of Cardio-Thoracic Surgery, Vol 10, 1120-1126, Copyright © 1996 by European Association for Cardio-thoracic Surgery

ARTICLES

A comparison of inhaled nitric oxide with intravenous vasodilators in the assessment of pulmonary haemodynamics prior to cardiac transplantation

D Pagano, JN Townend, R Horton, C Smith, T Clutton-Brock and RS Bonser
Cardiothoracic Surgical Unit, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK.

OBJECTIVE: Elevated pulmonary vascular resistance and transpulmonary gradient are predictors of increased perioperative mortality in patients undergoing orthotopic heart transplantation. Sodium nitroprusside and prostacyclin PGI2 are routinely used to assess the reversibility of pulmonary vascular resistance and transpulmonary gradient in heart transplant candidates, but their use is limited by their systemic vasodilatory effect. The aim of this study was to evaluate the systemic and pulmonary haemodynamic effects of low concentration (10 and 20 parts per million) inhaled nitric oxide in patients with severe heart failure with elevated transpulmonary gradient and pulmonary vascular resistance undergoing assessment for cardiac transplantation, and to compare the haemodynamic effects of inhaled nitric oxide with those of sodium nitroprusside and prostacyclin PGI2. METHOD: In 10 consecutive patients with elevated transpulmonary gradient (16+/-2 mm Hg) and pulmonary vascular resistance (3.6 +/-0.3 Wood units (WU)) nitric oxide (10 and 20 parts per million in 23% inspired oxygen (O2) via a tight fitting facemask) and increasing doses of intravenous sodium nitroprusside and prostacyclin were administered in a random, single-blinded fashion. RESULTS: Inhalation of nitric oxide (10 ppm) reduced the transpulmonary gradient (-7+/-2 mm Hg; P<0.01) and pulmonary vascular resistance (- 1.8+/-0.4 WU; P<0.001) but did not affect the systemic vascular resistance (-0.3+/-1 WU) or mean systemic arterial pressure (-1.3 5 mm Hg). Sodium nitroprusside and prostacyclin reduced the transpulmonary gradient (-4.5+/-2 mm Hg; P<0.01 and -3.6+/-2 mm Hg; P<0.05), pulmonary vascular resistance (-1.5+/-0.4 WU; P<0.001 and -1.3+/-0.4 WU; P<0.01), systemic vascular resistance (-7+/-2 WU; P<0.01 and -7.2+/-2 WU; P<0.01) and mean systemic arterial pressure (-15+/-5 mm Hg; P<0.01 and - 18+/-4 mm Hg; P<0.01). CONCLUSION: Low-concentration inhaled nitric oxide is as effective as sodium nitroprusside and prostacyclin in reducing transpulmonary gradient and pulmonary vascular resistance, and is highly pulmonary vasoselective.

This article has been cited by other articles:

				L. U. Nwakanma, A. S. Shah, J. V. Conte, and W. A. Baumgartner Heart Transplantation Card. Surg. Adult, January 1, 2008; 3(2008): 1539 - 1578. [Full Text]

				J. Martin, M. P. Siegenthaler, O. Friesewinkel, T. Fader, A. van de Loo, G. Trummer, M. Berchtold-Herz, and F. Beyersdorf Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation--a preliminary study Eur. J. Cardiothorac. Surg., June 1, 2004; 25(6): 971 - 977. [Abstract] [Full Text] [PDF]

				N. Adhikari and J. T. Granton Inhaled Nitric Oxide for Acute Lung Injury: No Place for NO? JAMA, April 7, 2004; 291(13): 1629 - 1631. [Full Text] [PDF]

				T. Kramm, B. Eberle, F. Krummenauer, S. Guth, H. Oelert, and E. Mayer Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy Ann. Thorac. Surg., September 1, 2003; 76(3): 711 - 718. [Abstract] [Full Text] [PDF]

				A. Sablotzki, E. Czeslick, S. Schubert, I. Friedrich, J. Muhling, M. G. Dehne, S. Grond, and T. Hentschel Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension: [L'iloprost ameliore l'hemodynamique chez des malades souffrant d'insuffisance cardiaque chronique et d'hypertension arterielle pulmonaire] Can J Anesth, December 1, 2002; 49(10): 1076 - 1080. [Abstract] [Full Text] [PDF]

				A. Sablotzki, T. Hentschel, E. Gruenig, S. Schubert, I. Friedrich, J. Muhling, M. G. Dehne, and E. Czeslick Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance Eur. J. Cardiothorac. Surg., November 1, 2002; 22(5): 746 - 752. [Abstract] [Full Text] [PDF]

				E. Michelakis, W. Tymchak, D. Lien, L. Webster, K. Hashimoto, and S. Archer Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial Hypertension: Comparison With Inhaled Nitric Oxide Circulation, May 21, 2002; 105(20): 2398 - 2403. [Abstract] [Full Text] [PDF]